APELIA研讨会（2024）将于2024年11月29-30日在日本神户大学召开。本次研讨会主题为“全球化与医疗保健/公共卫生面临的挑战：迈向跨学科的国际讨论”，将探讨生物医学、自然科学和社会科学在医疗保健和公共卫生领域的日益融合，以解决紧迫的全球性问题。数字医疗、生物制造和精准医疗的进步提高了对跨学科合作的需求，特别是从 ELSI（伦理、法律和社会问题）的角度，需要确保新技术的实施对社会负责。
APELIA 2024 Symposium
Globalisation and the Challenges for Healthcare/ Public Health:
Towards an International and Interdisciplinary Debate
● 会议议程 ●
Program
29th November (Fri)
13:00-13:15 Opening
13:15-14:45 Session 1: Global Healthcare and AI: Unprecedented Challenges
Shi Tonghe (Shanghai Jiao Tong University)
“The Global Rise of Data-Driven Intelligent Healthcare Systems”
Taixia Shen (Jinan University)
“AI Application in Healthcare in China: Human Rights Crisis or Opportunity?”
Ding Wen, Huang Qinqin & Sui Wanpeng (Ping An Health Insurance Company)
“Exploration of Health Wellness Management and Digital Application in Insurance Business”
Liu Zhiyi (Tongji University)
“Artificial Intelligence and Global Public Health DecisionMaking: Navigating Ethical, Legal, and Sociopolitical Complexities in the Era of Algorithmic Governance"
Guo Shoufu (Northwest University of Political Science and Law
“Regulatory Challenges and Pathways for AI Medical Devices: Ensuring Safety, Efficacy, and Innovation”
15:00-16:30 Session 2: Strategies for Global Regulation of Medical Resources and Information
Yu Jiajia (Shanghai Jiao Tong University)
"Bridging National Interests and Global Collaboration: China's Approach to Human Genetic Resource Management”
Zhao Yilin (National University of Singapore/ Zhejiang University) “Bridging the Divide on Health Data Flow: Legal Perspectives from Singapore and Mainland China”
Éloïse Gennet (Aix-Marseille University)
“Globalisation and the Challenges for Healthcare/Public Health: Towards an International and Interdisciplinary Debate”
Sun Xuan (Chinese University of Hong Kong)
“Health Rights Obligations of Transnational Pharmaceutical Companies in the Post-Pandemic Era: Is Consistent Interpretation an Effective Approach to Address the Failure of International Law?”
Jennifer Schulz (University of New South Wales/ Auckland University of Technology)
“The Role of Transnational Law in the Face of the Inability of Nation States to Respond to the Global Spread of Infectious Diseases”
16:45-18:30 Session 3: Humans, Culture, and Technology in the Age of Global Digitization
Man Hongjie & Yao Xuxin (East China University of Political Science and Law/ East China University of Political Science and Law & the University of Antwerp)
“12 Years after the Golden Rice Case, What Improvements We’ve Got?: Protection of Vulnerable Group in Clinical Trial in China”
Du Meixin (Xi'an Jiaotong University) “Cultural Perspectives on Overmedicalization in Palliative Care”
Yi Junlin (Shanghai Jiao Tong University)
“Trust in Healthcare: From Human Expertise to Technological Reliance”
Lin Jing (Shanghai Jiao Tong University)
“Medical Care: Booster to the City Development”
Di Zhang (Chinese Academy of Medical Science & Peking Union Medical College)
“Ethical Matrix for the Isolation of Infectious Diseases”
Xu Aiguo (Peking University)
“On the Legal Balance between Zoonosis Prevention and Animal Rights”
30th November (Sat)
9:00-11:00 Session 4: Exploring the Global Minimum for Healthcare: Disaster Medicine, Covid19 Measures and KBIC
Hiroshi Takahashi (Kobe University) “The Horizon of Collaborative Research in Law and Medicine"
Goh Ohji (Kobe University)
“The Role of Law in Addressing Medical Field Expectations"
Naoto Nishikawa (Kobe City, Planning and Coordination Bureau
“Challenges and Institutional Issues in KBIC”
Ji Weidong (Shanghai Jiao Tong University)
“Medical-Legal Research Collaboration and the Medical Industry City Initiative in Shanghai”
11:15-12:45 Session 5: Globalization, Public Health Care, and Intellectual Property Issues
Shi Yahan (City University of Hong Kong)
“The Tragedy of the Anti-Commons in New Drug R&D: The Dual Effect of Patent Thicket on Innovation“
Mark Zhang (King & Wood Mallesons)
“Unlock Pathways for Cross-Border Innovative Drug Development in China”
Huang Haiying (Xiangtan University) “Trust Breach Behavior and Regulatory Path in the Pharmaceutical Patent Linkage System with Particular in China”
Jia Liu (South China University of Technology)
“Unpacking Blockbuster Drug Sofosbuvir’s Patent Battles: Rethinking the Dynamics Between Intellectual Property Law and Innovation”
14:00-15:00 Executive Meeting
● 会议介绍 ●
Globalisation and the Challenges for Health Care/ Public Health:
Towards an Interdisciplinary and International Debate
This symposium will address the growing integration of biomedical, natural, and social sciences in healthcare and public health to tackle pressing global issues. Advances in digital health, bio-manufacturing, and precision medicine have heightened the need for interdisciplinary collaboration, particularly from the ELSI (ethical, legal, and social issues) perspective, ensuring socially responsible implementation of new technologies.
Globalization has simultaneously enabled the cross-border exchange of medical innovations and raised challenges. While diseases now spread rapidly worldwide, national responses have often proven insufficient. Additionally, the uneven distribution of medical resources, such as the high costs of breakthrough drugs, limits accessibility for economically disadvantaged populations. Cultural tensions further complicate medical provision, with differing attitudes on reproductive health, end-of-life care, traditional medicine, and vaccination.
Addressing these multifaceted challenges requires an international and collaborative approach that transcends individual disciplines, combining biomedical and natural sciences with social science perspectives. This symposium will convene experts from prominent institutions to promote interdisciplinary dialogue. Hosted by Kobe University, the event will leverage the institution’s social science expertise and its location in Kobe, a city recognized for the “Kobe Biomedical Innovation Cluster (KBIC)”. This setting offers a unique opportunityto incorporate insights from professionals actively engaged in the medical field, emphasizing practical approaches over theoretical discussions. Through this collaborative effort, the symposium aims to generate actionable solutions that can guide responsible, culturally sensitive, and equitable advancements in healthcare on a global scale.
Date: 29th November (Fri) & 30th November (Sat), 2024
Venue: Kobe University, Rokkodai 1st Campus, Frontier Hall
This Symposium is support by KU ‘Digital Bio & Life Science Research Park’ Initiative (DBLR) & The KU Center for Social Systems Innovation (KUSSI).